| | |
| 3799 | Guidelines Compliance for Prevention of Infective Endocarditis Among Saskatchewan Dentists
K. KOMIYAMA, J. QUIRING, N. LAING, and V. DHESI, University of Saskatchewan, Saskatoon, Canada |
| 3800 | Pharmacological Effect of COX-2 Inhibitor Nimesulid on the Gastro-Intestinal System
T.-H. LEE1, H.-C. SHIH1, M.-Y. CHOU1, and C.-Y. LEE2, 1Chung Shan Medical University, Taichung, Taiwan, 2Chung Shan Medical University Hospital, Taichung, Taiwan |
| 3801 | Rubber and Other Chemicals Type IV Allergy in Dental Professionals
C. SIEW1, C.P. HAMANN2, P.A. RODGERS2, D.L. HOGAN3, and S.E. GRUNINGER1, 1American Dental Association, Chicago, IL, USA, 2SmartPractice, Phoenix, AZ, USA, 3Louisiana State University Medical Center, Shreveport, USA |
| 3802 | Fluoride bioavailability from dentifrices in relation to pH and abrasive
K.P.K. OLYMPIO, P.A.P. BARDAL, V.E.S. CARDOSO, J.P. PESSAN, J.G. CARVALHO, J.R.P. LAURIS, and M.A.R. BUZALAF, Universidade de São Paulo, Bauru, Brazil |
| 3803 | Salivary Pharmacokinetics of a 5-day, 750 mg Dose of Metronidazole
V.A. KOZLOWSKI, Jr.1, A.D. HAFFAJEE2, F.C. GROPPO3, and J.M. GOODSON2, 1Ponta Grossa State University, UEPG/CNPq, Ponta Grossa, PR, BRAZIL, Forsyth Institute, Boston, MA, USA, 2Forsyth Institute, Boston, MA, USA, 3Faculty of Dentistry of Piracicaba/UNICAMP, Brazil |
| 3804 | Efficacy and pharmacokinetcs of itraconazole capsule in oral candidiasis
H. IWABUCHI1, K. UCHIYAMA1, E. SHIMOMURA1, R. WAKABAYASHI1, T. NAGAI2, K. TAKAMORI2, H. TSUNODA3, and K. TSUNODA4, 1Tochigi National Hospital, utsunomiya, Japan, 2Keio University, Tokyo, Japan, 3Keio University, tokyo, Japan, 4Keio University School of Medicine, Tokyo, Japan |
|